New collaboration launched to support the development of vaccines against henipavirus

A new collaboration between the UK Health Security Agency (UKHSA) and The Pirbright Institute has been launched to support the development of vaccines against henipavirus – a genus (or group) of viruses including Nipah virus.

Turn Bio and HanAll to develop therapies for age-related conditions

The companies will jointly develop therapies for age-related eye and ear ailments. Credit: Yurii_Yarema / Shutterstock.com. Turn Biotechnologies (Turn Bio) has entered an exclusive worldwide

May 29, 2024

This U.S. President Was Dying, but His Doctors Zipped Their Lips

The patient’s blood pressure averaged 209/100 mm Hg, a level now considered to be a medical emergency. His heart was enlarged, his skin was gray

July 17, 2024

QuidelOrtho test could miss heart attacks, drawing Class I recall

Dive Brief: QuidelOrtho’s recall of a test to detect heart attacks was labeled Class I by the Food and Drug Administration, the most serious type

July 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.